From owner-doc-jp@jp.FreeBSD.org Tue Jul  3 22:23:33 2007
Received: (from daemon@localhost)
	by castle.jp.FreeBSD.org (8.11.6p2+3.4W/8.11.3) id l63DNXV19143;
	Tue, 3 Jul 2007 22:23:33 +0900 (JST)
	(envelope-from owner-doc-jp@jp.FreeBSD.org)
Received: from china.com (61.155.38.58.broad.xw.sh.dynamic.163data.com.cn [58.38.155.61] (may be forged))
	by castle.jp.FreeBSD.org (8.11.6p2+3.4W/8.11.3) with ESMTP/inet id l63DNVB19136
	for <doc-jp@jp.freebsd.org>; Tue, 3 Jul 2007 22:23:31 +0900 (JST)
	(envelope-from china@china.com)
Message-Id: <200707031323.l63DNVB19136@castle.jp.FreeBSD.org>
Received: from STRAMARK02[192.168.0.144] by china.com
  with SMTP id 7C8D9C52; Tue, 3 Jul 2007 21:23:17 +0800
From: "China Growth Equities" <china@china.com>
To: "doc-jp" <doc-jp@jp.FreeBSD.org>
Content-Type: text/plain;
	charset="us-ascii"
Content-Transfer-Encoding: 8bit
X-Mailer: Microsoft Outlook Express 6.00.2800.1158
Reply-To: growthequities@china.com
Precedence: list
Date: Tue, 3 Jul 2007 21:23:37 +0800
X-Sequence: doc-jp 34273
Subject: [doc-jp 34273] CHINA GR0WTH EQUITIE5 =?GB2312?B?qENKdTF5LA==?= 2007.
Sender: owner-doc-jp@jp.FreeBSD.org
X-Originator: china@china.com
X-Distribute: distribute version 2.1 (Alpha) patchlevel 24e+060209

CHINA GR0WTH EQUITIE5 C Vo1ume 1, issue 4, Ju1y, 2007.

HFGB -Huifeng Bio-Pharmaceutica1 Techno1ogy Inc

D0NT MI55 THI5 HUGE PR0FIT 0PP0RTUNITY!!!!

M0RE Detai1s 1nvestmant Detai1s Avai1ab1e at:
Huifeng Bio-Pharmaceutica1 Techno1ogy Inc.
http://huifeng.mvhosted.com/ag.htm

P1ant Based Pharmaceutica1 And P1ant Based Nutraceutica1 
Products Are A Huge Growth Market In Asia!!!

Traditiona1 Chinese Medicine Is Part 0f This Trend.

HUGE GR0WTH I5 HAPPENING IN THE5E AREA5.  American 0rienta1 
Bioengineering (NY5E: A0B), has made a fortune producing these
products. http://finance.yahoo.com/q?s=aob  $8.90-

A0B Has Made Mi11ions For Its 5hareho1ders.  Here Is Another:-

C0MPANY:  Huifeng Bio-Pharmaceutica1 Techno1ogy, Inc.
5YMB01: HFGB (0TC Bu11etin Board). 
CURRENT PRICE: 0.50
TARGET PRICE(2 month): 2.80

NET 5A1E5 IN 2006: $3,000,000 (PR0FITAB1E)
EXPECTED 5A1E5 IN 2007: $6,000,000

WE EXPECT 5A1E5 T0 D0UB1E THI5 YEAR. FIR5T QUARTER RE5U1T5 ARE
0UT. 

M0RE Detai1s 1nvestmant Detai1s Avai1ab1e at:
Huifeng Bio-Pharmaceutica1 Techno1ogy Inc.
http://huifeng.mvhosted.com/ag.htm

In our opinion, HFGB I5 AN0THER A0B IN THE MAKING.
Based in 5haanxi Province, China, Huifeng (0TCBB: HFGB) is the
wor1ds 1eading producer of a nutraceutica1 ca11ed RUTIN.  
RUTIN is a p1ant extract which can he1p to stop diseases of 
the 1eg. 
RUTIN a1so he1ps protect against heart attacks and cerebra1 
hemorrhage. 
RUTIN is a p1ant based nutraceutica1.

G1oba1 demand for Rutin has been increasing at an annua1 rate 
of 30% as a resu1t of the aging popu1ation. Improvement in 
1iving standards in China is stimu1ating the growth in the 
demand for Traditiona1 Chinese Medicine, which is huge1y 
popu1ar there.  

Huifeng Is Positioned To Profit From The Boom In Wor1d Demand 
For Chinese P1ant-Based Nutraceutica1s And Traditiona1 Chinese
 Medicine.  Add This 0ne To Your Portfo1io Today!!!

TAKE ACTI0N N0W!! MAJ0R CAMPAIGN UNDERWAY!

M0RE Detai1s 1nvestmant Detai1s Avai1ab1e at:
Huifeng Bio-Pharmaceutica1 Techno1ogy Inc.
http://huifeng.mvhosted.com/ag.htm




____________________________________
Disc|a1mer:
Information within this em4i| c0nta1ns "f0rw4rd |0ok1ng 
st4t3ments" within the meaning of 5ect10n 27Aof the 
5ecur1ties Act of 1933 and 5ecti0n_21B of 
the5ecur1ties_Exchange_Act of 1934. Any statements that 
express or inv01ve discussi0ns with respect to  pred1cti0ns
, expectati0ns, be|iefs, p|ans, pr0jecti0ns, objectives, 
goa1s, assumptions or future events or performance are not
 statements of historica1fact and may be "f0rw4rd |0ok1ng 
st4t3ments". "f0rw4rd |0ok1ng st4t3ments" are based on 
expectations, estimates and pr0jections at the time the 
statements are made that invo1ve a number of risks and 
uncertainties which cou1d cause actua1 resu1ts or events 
to differ materia11y from those present1y anticipated. We 
were paid a sum of three th0us4nd U5D to disseminate 
thisinformation from ir marketing. f0rw4rd |0ok1ng 
st4t3ments in this action may be identified through the 
use of words such as "projects", "f0resee", "exp3cts", 
"wi||", ant1cipates", "est1mates", "be|ieves", 
"understands" or that by statements indicating certain 
acti0ns "may", "c0u1d", or "might" occur. Risk fact0rs 
inc1ude genera1 economic and business conditions, the 
abi1ity to acquire and deve1op specific projects, the 
abi1ity to fund operations and changes in consumerand 
business consumption habits and other factors over which 
the company has 1itt1e or no contro1. The pub1isher of 
this news|etter does not represent that the  information 
contained herein are true and correct


